Effect of Rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: The LINK-IT trial

Not Applicable

• Conditions: coronary artery disease patient with in-stent neoatherosclerosis

• Registration Number: JPRN-UMIN000012576
• Lead Sponsor: Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-12-14
• Study Completion: 2017-06-02
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

Patients meeting one of the following conditions will be excluded: 1) severe liver dysfunction 2) renal dysfunction (<Cre 2.0mg/dL) 3) severe heart failure (NYHA/New York Heart Association stage III or severer) 4) malignancies or other diseases with poor prognosis 5) pregnant, lactating, and possibly pregnant women and those planning to become pregnant 6) past medical history of hypersensitivity to investigational drugs 7) judged as ineligible by clinical investigators

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in lipid index analyzed by optical coherence tomography

Secondary Outcome Measures

Name	Time	Method
Ischemic driven TLR, MACE(death, myocardial infarction, TLR), and stent thrombosis, other OCT parameters